RESEARCH-USE BIOSIMILAR ANTIBODY
Afasevikumab
Monoclonal antibody · IgG1
Afasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities.
TARGETIL17A
YMonoclonal antibody
CATALOGSC-BS-781
CATALOG NUMBERSC-BS-781
MOLECULAR WEIGHTApprox. 146.065 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Afasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities.
Afasevikumab is a recombinant research-use antibody directed against IL17A.